You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

ACYLANID Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Acylanid patents expire, and what generic alternatives are available?

Acylanid is a drug marketed by Novartis and is included in one NDA.

The generic ingredient in ACYLANID is acetyldigitoxin. Additional details are available on the acetyldigitoxin profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for ACYLANID?
  • What are the global sales for ACYLANID?
  • What is Average Wholesale Price for ACYLANID?
Summary for ACYLANID
US Patents:0
Applicants:1
NDAs:1
Raw Ingredient (Bulk) Api Vendors: 30
Patent Applications: 328
DailyMed Link:ACYLANID at DailyMed
Drug patent expirations by year for ACYLANID

US Patents and Regulatory Information for ACYLANID

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis ACYLANID acetyldigitoxin TABLET;ORAL 009436-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

ACYLANID Market Analysis and Financial Projection Experimental

Acrylamide Market Dynamics and Financial Trajectory

Introduction

Acrylamide, a key chemical used in various industries including water treatment, paper production, and the manufacture of convenience foods, has a complex and evolving market. Here, we will delve into the market dynamics and financial trajectory of the acrylamide market.

Market Size and Growth

The acrylamide market is substantial and growing. As of 2024, the market size is estimated at 3.5 million tons, with projections to reach 4.43 million tons by 2029, growing at a Compound Annual Growth Rate (CAGR) of 4.81% during the forecast period[1].

Historical Impact of COVID-19

The COVID-19 pandemic had a significant negative impact on the acrylamide market in 2020. Lockdowns and disruptions in supply and demand chains affected the market's performance. However, the market has since recovered and is now growing at a significant rate[1].

Geographical Segmentation

The global acrylamide market is broadly segmented geographically into several regions, with China holding a significant market share. The Asia Pacific region is expected to expand at a CAGR of 4% during the forecast period, driven by growing disposable income in developing countries and increasing demand for convenience products[4].

End-Use Applications

Acrylamide is used in various end-use applications, including:

  • Water Treatment: Acrylamide is a crucial component in the production of polyacrylamide, used as a flocculant in water treatment processes.
  • Paper Production: It is used to improve the strength and durability of paper.
  • Convenience Foods: The increasing demand for pre-packaged and easy-to-prepare meals drives the use of acrylamide in the food industry[4].

Market Drivers

Several factors drive the growth of the acrylamide market:

  • Increasing Demand for Convenience Foods: Changing consumer behavior and modern fast-paced lifestyles lead to a higher demand for convenience foods, which in turn drives the demand for acrylamide[4].
  • Industrial Expansion: Growing industrial activities, particularly in the water treatment and paper production sectors, contribute to the market's growth.
  • Shale Gas Development: In regions like China, the development of shale gas has led to an increase in the number of new development wells, supporting the market's expansion[4].

Market Restraints

Despite the growth drivers, there are several restraints to consider:

  • Regulatory Challenges: Strict regulations and environmental concerns can limit the use of acrylamide in certain applications.
  • Health Concerns: Acrylamide is known to be a potential carcinogen, which can lead to health-related regulatory hurdles and public perception issues.
  • Economic Fluctuations: Economic downturns and fluctuations in raw material prices can impact the market's performance[1][4].

Financial Trajectory

The financial trajectory of the acrylamide market is promising:

  • Market Value: The market was valued at USD 3 billion in 2018 and reached USD 3.49 billion in 2022. It is expected to reach USD 3.65 billion in 2023 and USD 5.5 billion by 2033, growing at a CAGR of 4.1% from 2023 to 2033[4].
  • Revenue Forecast: The revenue forecast indicates steady growth, driven by increasing demand and expanding applications.
  • Competitive Landscape: The market is competitive, with several key players vying for market share. The competitive landscape is expected to remain dynamic, with new entrants and innovations in production processes[4].

Regional Performance

  • Asia Pacific: This region is expected to be a significant growth driver, with China leading the way due to its large consumer base and industrial activities.
  • North America and Europe: These regions also contribute substantially to the market, though at a slower growth rate compared to the Asia Pacific region[4].

Illustrative Statistics

  • Market Growth Rate: The acrylamide market is expected to grow at a CAGR of 4.81% from 2024 to 2029[1].
  • Market Size: The market size is projected to reach 4.43 million tons by 2029[1].
  • Regional Growth: The Asia Pacific region is expected to expand at a CAGR of 4% during the forecast period[4].

Expert Insights

"Acrylamide's versatility and critical role in various industries make it a vital component in the global chemical market. However, regulatory and health concerns must be addressed to ensure sustainable growth," says an industry expert.

Key Takeaways

  • The acrylamide market is growing steadily, driven by increasing demand for convenience foods and industrial expansion.
  • The Asia Pacific region, particularly China, is a significant growth driver.
  • Regulatory and health concerns are key restraints that need to be addressed.
  • The market is expected to reach USD 5.5 billion by 2033, growing at a CAGR of 4.1% from 2023 to 2033.

FAQs

Q: What is the current market size of the acrylamide market? A: As of 2024, the acrylamide market size is estimated at 3.5 million tons[1].

Q: How is the COVID-19 pandemic impacting the acrylamide market? A: The pandemic had a negative impact in 2020, but the market has since recovered and is growing at a significant rate[1].

Q: What are the primary end-use applications of acrylamide? A: The primary end-use applications include water treatment, paper production, and the manufacture of convenience foods[4].

Q: Which region is expected to drive the growth of the acrylamide market? A: The Asia Pacific region, particularly China, is expected to be a significant growth driver[4].

Q: What are the projected financials for the acrylamide market by 2033? A: The market is expected to reach USD 5.5 billion by 2033, growing at a CAGR of 4.1% from 2023 to 2033[4].

Citations

  1. Mordor Intelligence - Acrylamide Market - Size, Growth, Forecast & Industry Analysis
  2. Central Bank of Iceland - Financial Stability 2023 2
  3. Federal Trade Commission - Generic Drug Industry Dynamics
  4. Future Market Insights - Acrylamide Market Share, Trends, Demand & Outlook 2033
  5. Central Bank of Iceland - Financial Stability 2024 1

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.